Elevated plasma chitotriosidase activity in various lysosomal storage disorders

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  1995-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02436762PMID 8750610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

  1994cited by this paper
• Non-identity of human plasma lysozyme and 4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase.

  1988cited by this paper

• Clinical and genetic analyses of 17 Chinese patients with glycogen storage disease type IXc

  2025influential citation
• Glucosylsphingosine affects mitochondrial function in a neuronal cell model

  2025cites this paper
• 3D structural insights into the effect of N-glycosylation in human chitotriosidase variant G102S.

  2024cites this paper
• Plasma chitotriosidase enzyme activity as a novel therapeutic monitor for cysteamine treatment in nephropathic cystinosis: A retrospective validation study.

  2024cites this paper
• Cystinosis — a review of disease pathogenesis, management, and future treatment options

  2024cites this paper
• A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients—A Qualitative and Quantitative Approach

  2023cites this paper
• Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

  2023cites this paper
• Plasma glucosylsphingosine correlations with baseline disease burden and response to eliglustat in two clinical trials of previously untreated adults with Gaucher disease type 1.

  2023cites this paper
• Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review

  2023cites this paper
• Exploratory Evaluation of Neopterin and Chitotriosidase as Potential Circulating Biomarkers for Colorectal Cancer

  2023cites this paper
• Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1

  2022cites this paper
• Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease

  2022cites this paper
• Evaluation of Circulating Chitotriosidase Activity in Children with Obesity

  2022cites this paper
• Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives

  2022cites this paper
• The chitinases as biomarkers in immune-mediate diseases

  2022cites this paper
• The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)

  2021cites this paper
• GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice

  2021cites this paper
• Increased Plasma YKL-40 Level and Chitotriosidase Activity in Cystic Fibrosis Patients

  2021cites this paper
• Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases

  2021cites this paper
• Diagnostic biochimique et moléculaire des maladies de surcharge lysosomale avec anomalies cytologiques

  2021cites this paper
• Chitotriosidase as a biomarker for gangliosidoses

  2021cites this paper
• Glycoside hydrolase family 18 chitinases: The known and the unknown.

  2020cites this paper
• Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.

  2020cites this paper
• LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population

  2020cites this paper
• Beyond the Typical Syndrome: Understanding Non-motor Features in Niemann-Pick Type C Disease

  2020cites this paper
• Clinical significance of chitotriosidase in outpatients with advanced heart failure

  2020cites this paper
• Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots

  2020cites this paper
• Beyond the Typical Syndrome: Understanding Non-motor Features in Niemann-Pick Type C Disease

  2020cites this paper
• Lysosomal enzyme deficiency and GBA mutations in Dystonia

  2020influential citation
• Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis

  2019cites this paper
• Oxysterol/chitotriosidase based selective screening for Niemann-Pick type C in infantile cholestasis syndrome patients

  2019cites this paper
• Twenty- five years of biochemical diagnosis of Gaucher disease: the Egyptian experience

  2019cites this paper
• Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease

  2019cites this paper
• Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months

  2018cites this paper
• Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages

  2018cites this paper
• Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project.

  2018cites this paper
• Acute Gaucher Disease-Like Condition in an Indian Infant with a Novel Biallelic Mutation in the Prosaposin Gene

  2018cites this paper
• Utility of amniotic fluid chitotriosidase in the prenatal diagnosis of lysosomal storage disorders.

  2018cites this paper
• Plasma chitotriosidase activity versus plasma glucosylsphingosine in wide spectrum of Gaucher disease phenotypes - A statistical insight.

  2018cites this paper
• Human Chitotriosidase Does Not Catabolize Hyaluronan.

  2018cites this paper
• Serum chitotriosidase enzyme activity is closely related to HbA1c levels and the complications in patients with diabetes mellitus type 2.

  2017cites this paper
• Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.

  2017cites this paper
• Mutational analysis of a cohort of Egyptian patients with Gaucher disease

  2017influential citation
• Scleroderma-Associated Interstitial Lung Therapeutic Target in Chitinase 1 Is a Biomarker for and

  2017cites this paper
• Chitotirosidase and prolidase in tinea pedis: A preliminary study -

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Glycosphingolipids and the central regulation of metabolism Sugar analogues as research tools

  2017cites this paper
• Date of Patent : ( 54 ) MEANS AND METHODS FOR DETECTING ENDOGLYCOSIDASE ACTIVITY

  2017cites this paper
• The modulation of inflammatory parameters, Brain-derived neurotrophic factor levels and global histone H4 acetylation status in peripheral blood of patients with Gaucher disease type 1.

  2017cites this paper
• Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study

  2017cites this paper
• New Developments in 1H NMR-linked Metabolomics: Identification of New Biomarkers for the Metabolomic Classification of Niemann-Pick Disease, Type C1, and its Response to Treatment

  2016cites this paper
• Association of chitotriosidase enzyme activity and genotype with the risk of nephropathy in type 2 diabetes.

  2016cites this paper
• Allelic Frequency of a 24-bp Duplication in Exon 10 of the CHIT1 Gene in the General Iranian Population

  2016cites this paper
• Decreased Chitotriosidase Activity and Levels in Familial

  2016cites this paper
• Otorhinolaryngological, audiovestibular and swallowing manifestations of patients with Niemann-Pick disease Type C.

  2016cites this paper
• Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever

  2016cites this paper
• Clinical use of plasma chitotriosidase in severe sepsis

  2016cites this paper
• Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A/B diseases: A retrospective study from India.

  2016cites this paper
• Chitotriosidase deficiency in the Cypriot population: Identification of a novel deletion in the CHIT1 gene.

  2016cites this paper
• Diagnostic workup and management of patients with suspected Niemann-Pick type C disease

  2016cites this paper
• Zarys objawów klinicznych, leczenia oraz trudności w rozpoznawaniu choroby Gauchera

  2015cites this paper
• Serum cystatin C and chitotriosidase in acute P-407 induced dyslipidemia: Can they serve as potential early biomarkers for atherosclerosis?

  2015cites this paper
• Distinct Niemann-Pick Disease Type C Clinical, Cytological, and Biochemical Phenotype in an Adult Patient With 1 Mutated, Overexpressed NPC1 Allele

  2015cites this paper
• Serum chitotriosidase levels in cancer patients undergoing high dose chemotherapy and stem cell transplantation.

  2015cites this paper
• Guía para diagnóstico y tratamiento de la Enfermedad de Gaucher Guidelines for diagnosis and treatment of Gaucher Disease

  2015cites this paper
• Recent Advances in the Diagnosis and Treatment of Niemann-Pick Disease Type C in Children: A Guide to Early Diagnosis for the General Pediatrician

  2015cites this paper
• LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases.

  2015cites this paper
• Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes

  2015cites this paper
• S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever

  2015cites this paper
• Dup-24 bp in the CHIT1 Gene in Six Mexican Amerindian Populations.

  2015influential citation
• Evaluation of 24 Bp Duplication of Chitotriosidase Gene in Pulmonary Tuberculosis in Zahedan, Southeast Iran: A Preliminary Report

  2015cites this paper
• Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis

  2014cites this paper
• The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease

  2014cites this paper
• The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease

  2014cites this paper
• Wartość diagnostyczna i zastosowanie kliniczne biomarkerów oraz ferrytynemii w chorobie Gauchera

  2014cites this paper
• Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses.

  2014cites this paper
• Blood spot versus plasma chitotriosidase: a systematic clinical comparison.

  2014cites this paper
• Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major

  2014cites this paper
• Role of Changes in Serum Chitotriosidase Activity in Mice under Conditions of Hyperlipidemia and Lipid-Lowering Effect of Carboxymethylated (1-3)-β-D-Glycan

  2014cites this paper
• Serum dipeptidyl peptidase-IV: a better screening test for early detection of mucopolysaccharidosis?

  2014cites this paper
• Cholesterinester speicherkrankheit (CESD)

  2014cites this paper
• Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease

  2014cites this paper
• Fifteen years experience: Egyptian metabolic lab

  2014cites this paper
• Structural insights into chitinolytic enzymes and inhibition mechanisms of selective inhibitors.

  2014cites this paper
• Early manifestations of Anderson Fabry disease

  2013cites this paper
• Chitotriosidase Activity in Normal Pregnancies and in Abortions

  2013cites this paper
• Chitinase inhibition promotes atherosclerosis in hyperlipidemic mice.

  2013cites this paper
• Clinical and Diagnostic Findings of 19 Gaucher Patients in Albania

  2013cites this paper
• Stoffwechselerkrankungen

  2013cites this paper
• Association of chitotriosidase genotype with the development of non‐alcoholic fatty liver disease

  2013cites this paper
• Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?

  2013cites this paper
• Serum chitotriosidase activity in acute coronary syndrome.

  2013cites this paper
• Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.

  2013cites this paper
• CHIT1 genetic defects in the Portuguese population.

  2013cites this paper
• ˆtre un marqueur possible d'une mycose invasive ?

  2012cites this paper
• Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?

  2012cites this paper
• Can chitotriosidase be a surrogate marker for invasive fungal disease?

  2012cites this paper
• Inflammatory marker levels in obese adolescents with glucose intolerance: increased chitotriosidase activity.

  2012cites this paper
• Role of chitotriosidase (chitinase 1) under normal and disease conditions.

  2012cites this paper
• The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart.

  2012cites this paper
• Chitotriosidase deficiency: a mutation update in an african population.

  2012cites this paper